Finward Bancorp’s BioNTech BNTX Stock Holding History

Finward Bancorp’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,935	Closed	-$261K	–	108
2026 Q1	$261K	Sell	2,935 -5	-0.2%	-$514	0.21%	90
2025 Q4	$280K	Sell	2,940 -10	-0.3%	-$1.01K	0.22%	87
2025 Q3	$291K	Sell	2,950 -5	-0.2%	-$535	0.22%	84
2025 Q2	$315K	Hold	2,955	–	–	0.25%	82
2025 Q1	$269K	Sell	2,955 -10	-0.3%	-$1.12K	0.23%	88
2024 Q4	$338K	Buy	+2,965	New	+$338K	0.29%	77

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Finward Bancorp's BNTX Position: Q2 2026 in Review

Finward Bancorp sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 2,935 shares — an estimated $261K sold.

Finward Bancorp first reported a position in BNTX in Q4 2024 and held it in 6 quarters. The position peaked at $338K in Q4 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Finward Bancorp reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
Finward Bancorp sold 2,935 BioNTech shares in Q2 2026, an estimated $261K.
Finward Bancorp first reported a position in BioNTech in Q4 2024 and held it in 6 quarters.
Finward Bancorp's BioNTech position peaked at $338K in Q4 2024.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Finward Bancorp's 13F filing for Q2 2026, filed 16 Jul 2026.